TMCnet News

GETA, CVAT, HZHI. X-Tra Hot Watch List! by for Monday Nov 23, 2009
[November 22, 2009]

GETA, CVAT, HZHI. X-Tra Hot Watch List! by for Monday Nov 23, 2009

***FREE Stock Alerts*** From CRWENEWSWIRE's Click on the link Below: __ GETA, Genta Incorporated, GETA.OB GETA is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer.

GETA's lead oncology product, Genasense® (oblimersen sodium) Injection Given as High-Dose IV Infusion with Chemotherapy {temozolomide (Temodar®; Schering Plough, Inc.), the most commonly used anticancer drug for melanoma, and Abraxane® (paclitaxel protein-bound particles for injectable suspension [albumen bound]; Abraxis Bioscience, Inc.} Shows Promising Activity in a pilot study of patients with Advanced Melanoma which it's the most deadly form of skin cancer.

The incidence of Malignant melanoma is increasing by approximately 4% annually in the U.S. Melanoma is the number one cause of cancer death in women aged 25 to 29.

__ CVAT, Cavitation Technologies Inc, CVAT.OB CVAT is a “Green-Tech” company, established in 2006 to become a world leader in the development of new cutting edge technologies for the vegetable oil refining, renewable fuel, petroleum, water treatment, wastewater sanitation, food and beverage, and chemical industries.

CVAT continues to identify new applications for its technology. All of the applications are in industries where there is a need to solve environmental problems, reduce operating costs and improve profitability.

The technologies CVAT is developing will have international impact. For that reason, CVAT needed to file International Patents to protect its Nano Cavitation Technologies & Intellectual Properties worldwide.

**Read the next Carefully ** ** CVAT has filed three new PCT patent applications to protect its intellectual property worldwide: - Flow-Through Cavitation Assisted Rapid Modification of Crude Oil, designed to increase the yield of refining crude petroleum. CVAT conducted tests whereby its cavitation technology was used to produce 5% to 15% more diesel and gasoline from the same barrel of crude oil at lower temperatures.

- Modification of Beverage Fluids. The Modification of Beverage Fluids using wine aging as an example, Cavitated and electrolyzed wine is healthier because it doesn’t oxidize easily and requires no artificial anti-oxidizing agents that are present in almost all wines. Cavitation improves the color, palatability, mellowness and bouquet in minutes rather than in the months or years that is needed for a similar result through normal aging.

- Method for Cavitation Assisted Refining, Degumming and Dewaxing of Oil and Fat. CVAT's degumming system converts crude non-degummed vegetable oils into high quality degummed oils using only water and/or trace amounts of citric acid. In many tests conducted, CVAT processed crude vegetable oils with trace amounts of citric acid and/or caustic to levels that are acceptable to both, physical and chemical refining. An improvement of more than 80% compared to typical hot water degumming that reduces gums to about 200 PPM (News - Alert).

CVAT is filing patents in order to protect its superior technologies globally.

__ HZHI, Horizon Health International Corp., HZHI.PK HZHI through its US and Canadian Subsidiaries is at present servicing all of North America through its E-Commerce System, as a ‘Home, Office and Workplace Medical Equipment Specialist’ offering a complete end-to-end shopping experience for aids for daily living, disability products, ergonomic solutions and leading-edge assistive technology through online retail stores across North America.

BCC (News - Alert) Research reported that: "The US market for assistive technology is expected to be worth $ 38.2 billion in 2008, up from 36.4 billion in 2007. This should increase to 49.3 billion in 2013, a compound annual growth rate (CAGR) of 5.3%" Recently, HZHI reported the successful launch of their e-commerce website MEDIchair-Calgary (with estimated annual sales of $ 5 million plus) will pay to Samson Industries (HZHI's wholly owned subsidiary) a monthly license fee of $250 plus 50% of the profit realized from on-line sales generated by MEDIchair through HZHI's website. HZHI will be entering into discussions with all the 70 franchisees of MediChair Corporate to license its website.

HZHI has commenced the development of two new websites to speed up the process of orders, www.horizonhealthandsafety-canada for all transactions within Canada and www.horizonhealthandsafety-us for all transactions within the US. The sites will be completed and will be operational within 14 days.

Furthermore, trough its US Subsidiary SunCity Ventures, HZHI has registered with eBay (News - Alert) US as a Vendor-Company under the name 'Horizon Health', and will post and sell its products on eBay through their online shopping network.

__ About is a stock watch website, a Division that provides free daily alerts on stocks.'s alerts are daily e-mail on stocks that are hot in the market. These include stocks with huge volume, penny stocks, stocks with technical indicators and much more. also tracks small cap stocks that are on the brink of moving upwards. also features companies on its website with research report, analysis, and newsletters. is an independent electronic publication that provides information on selected publicly traded companies. is not a registered investment advisor or broker-dealer. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Please do your own Due Diligence before investing in any of the stocks mentioned above. The disclaimer is to be read and fully understood before using our sites, stock alerts, watch list or joining our email list. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc has been compensated in a joint venture with $25,000 dollars from a third party for advertisment services for HZHI.PK, Horizon Health International Corp. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand shares of free trading stock from a third party for advertising services for Cavitation Technologies, Inc. (CVAT.OB) and an additional twenty-five thousand shares of 144 restricted stock from Cavitation Technologies, Inc. (CVAT.OB) for 12 months of advertisement services. Full disclaimer can be read at

We encourage investors to join the FREE e-mail alerts by visiting: About is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. is a division of Crown Equity Holdings, Inc.

***FREE STOCK ALERTS** Sign up to receive FREE stock alerts from CRWENewswire's at Forward Looking Statement This press release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. With the exception of historical information contained herein, the matters discussed in this press release involve risk and uncertainties. Actual results could differ materially from those expressed in any forward-looking statement.

Contact [email protected]

As a community-building service, TMCnet allows user submitted content which is not always proofed by TMCnet editors. If you feel this entry is of inferior quality or wish to report it for some reason, please forward the URL to "webedit [AT] tmcnet [DOT] com" with your comments.

[ Back To's Homepage ]